Most obesity benefits start and end with a prescription. Embla starts with a dedicated coach, adds low-dose GLP-1s only when an independent licensed clinician finds them appropriate, and plans the way off medication from day one.
Type 2 diabetes, high blood pressure, sleep apnea and joint pain often each get their own vendor. Obesity sits upstream of all of them.
GLP-1s changed what is possible. But covered on their own, they become an open-ended pharmacy line. Doses climb, side effects push people off, and weight tends to return when they stop.
Obesity is complicated because people are. Care that works has to treat it that way.
.avif)
Andrea Robinson, Head of US Coaching and a National Board Certified Health and Wellness Coach.
Every member gets a dedicated coach trained in Acceptance and Commitment Therapy. Together they work on what drives weight: stress, sleep, emotional eating and daily routines.
Independent licensed clinicians decide whether a GLP-1 is appropriate. If it is, they aim for the lowest effective dose. Members in our TRIM study averaged less than half the standard maximum.
Tapering starts at month 16 and runs over about 12 weeks, with coaching throughout. Embla Embrace then helps members keep their results.
1:1 coaching on nutrition, movement, sleep, stress and emotional eating. No medication.
Everything in EmblaThrive, plus low-dose GLP-1s when a clinician finds them appropriate, and a planned taper.
Continued coaching and check-ins after weight loss or after a taper.
Also managing type 2 diabetes, blood pressure or cholesterol? See EmblaRestore
TRIM study: Seier et al., Diabetes, Obesity and Metabolism, 2025 (n=2,694). TRIM is Embla’s own peer-reviewed research. Case study results reflect one employer and are not a guarantee for your group. Individual results vary. Read the TRIM study
Members at self-funded employers on the doubts they started with and the habits that finally stuck.
“I can't believe I've become this person that actively makes better choices.”
“I thought I was weak. I was wrong.”
“I'll admit, I originally thought having to speak with a coach would be inconvenient and not very helpful. But I've been pleasantly surprised.”
Embla member, joined through work
“We were initially a bit apprehensive about the GLP medications, but we were encouraged by how they were positioned as one resource in the overall journey, not the only solution.”
Embla member, joined with his wife
“I'm surprising myself. I never thought I'd be this consistent with something, because usually I started something then went back to how I was used to doing it.”
Embla member, joined through work
“My coach consistently checks in, even outside of scheduled coaching sessions, listens without judgment, and provides encouragement whenever I am feeling discouraged.”
Embla member, joined through work
A fully managed obesity care benefit that sits next to the plan you already have.
Coaching, clinical care and medication in one fee. You only pay for employees who take part.
If doses rise, the cost is ours. So we are paid to keep doses at the lowest effective level.
A true carve-out. Your medical plan and PBM stay as they are.
Medication is sourced at a lower price, one of the ways GLP-1 costs can fall by up to half.
We run the launch: eligibility file, employee emails, posters and a dedicated enrollment page.
Regular population-level reports on engagement, weight and medication use.
No. Embla is a carve-out for obesity care. Your medical plan and PBM stay as they are, and GLP-1s for weight loss run through Embla.
You decide with us, usually by BMI and weight-related conditions. Whether medication is appropriate is always decided by an independent licensed clinician.
No. EmblaThrive is coaching only, and many members never need medication.
They start where they are. Any change to their dose comes later, once an independent licensed clinician has reviewed how they are doing.
Tapering is structured, begins at month 16 and is supported by coaching. Embla Embrace helps members keep their results afterwards.
One fixed fee per engaged member, medication included. You can also tie GLP-1 coverage to program participation.
No, and we say so up front. TRIM is Embla’s own study, peer-reviewed and published in Diabetes, Obesity and Metabolism in 2025.
No. The app supports the program, but every member works with a human coach, with clinicians, nurses and pharmacy on the same platform.
Tell us your headcount and current GLP-1 spend. We’ll show you how Embla fits, what it costs and how launch works.
You’ll talk to Claudia, Brad or Paul, who work with employers and benefits consultants every day.